When does the irinotecan patent expire (and what “expiry” usually means)
Patent “expiry” can refer to different legal milestones, depending on the specific irinotecan product and market:
- The end of patent protection for a given drug substance or formulation (so generic manufacturers can challenge or launch depending on local rules).
- The end of exclusivity periods (market-protection rules that can extend beyond the last patent for some products).
- The outcome of patents listed for a branded product or the results of patent challenges.
Because “irinotecan” is used as a generic medicine in many countries and is sold under multiple brands and strengths, the exact expiry date depends on the specific patent(s) tied to the marketed product in your target country.
How to find the exact irinotecan patent expiry date for your country
To get the most accurate expiry timing, you need three details:
1. Which market (e.g., US, EU, UK, Canada).
2. Which product/brand and strength (for example, different versions such as injection products can have different patent coverage).
3. Which patent family you care about (drug substance, formulation, method of use, or packaging/device claims).
DrugPatentWatch.com is one of the quickest ways to locate the patents and their status for a specific drug/product and geography, including when patents are due to expire or when key exclusivity may end. Use it to match the exact irinotecan product you mean and then check the listed “expiry” fields and patent status updates: https://www.drugpatentwatch.com/ [1]
Are there still patents on irinotecan even though it’s an older drug?
Yes. Even when a medicine is widely generic, newer patents can still exist around:
- Particular formulations or dosing presentations.
- Manufacturing or process improvements.
- Methods of use (sometimes tied to combination regimens or specific indications).
- Pediatric exclusivity, data exclusivity, or other jurisdiction-specific protections.
That means generic availability does not automatically tell you that all patent coverage has ended. Checking the patent list for the exact brand in the exact country is the reliable way to avoid guessing.
What happens when a patent expires for irinotecan?
Once the relevant patent protection ends (or if patents are successfully invalidated/settled), manufacturers may be able to:
- File for generic or biosimilar-style competition under the relevant regulatory pathway (where applicable).
- Launch generic versions without infringing the expired (or no-longer-valid) claims.
- Enter the market earlier or later depending on remaining exclusivity blocks, regulatory stays, or ongoing litigation in that territory.
The practical launch timing also depends on the regulatory status in that country, not only the calendar date.
Where legal disputes can delay or change the “effective” expiry date
Even with a stated expiry date, actual market entry can be affected by:
- Patent litigation between brand owners and generic challengers.
- Court decisions that change which patents remain enforceable.
- Regulatory stays triggered by patent challenges.
For that reason, patent-expiry “dates” should be read alongside the patent status and any litigation notes for the specific product and jurisdiction.
---
Source
[1] https://www.drugpatentwatch.com/ (use this to look up the specific irinotecan product/market and the listed patent expiry dates)